ATYR PHARMA INC (ATYR) Stock Income Statement
NASDAQ:ATYR - Nasdaq - US0021202025 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 235.00K | 353.00K | 10.39M | 0.00 | 10.46M | |||
| Minority Interest Expense | -1.00K | 8.00K | 5.00K | 9.00K | 6.00K | |||
| Operating Expenses | 68.15M | 55.27M | 56.79M | 34.02M | 26.37M | |||
| Research and Development | 54.37M | 42.29M | 42.81M | 23.26M | 17.29M | |||
| Selling, General, and Administrative Expenses | 13.78M | 12.98M | 13.98M | 10.75M | 9.07M | |||
| Operating Income | -67.91M | -54.92M | -46.40M | -34.02M | -15.91M | |||
| Interest Income/Expense | N/A | N/A | N/A | N/A | N/A | |||
| Other Income/Expense | 3.89M | 4.52M | 1.06M | 238.00K | -319.00K | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | -64.02M | -50.40M | -45.34M | -33.78M | -16.23M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -64.02M | -50.39M | -45.34M | -33.77M | -16.22M | |||
| EBITDA | -67.21M | -54.33M | -46.17M | -33.54M | -15.34M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.86 | -0.94 | -1.60 | -1.77 | -1.77 | |||
| Non GAAP EPS | -0.87 | -0.96 | -1.60 | -1.88 | -1.59 | |||
| Statistics | ||||||||
| Profit Margin | -27243.83% | -14274.50% | -436.53% | N/A | -155.18% | |||
| Operating Profit Margin | -28899.57% | -15557.79% | -446.79% | N/A | -152.19% | |||
All data in USD